Farastuk Bozorgmehr

<i>C. elegans</i> as Model for the Study of High Glucose– Mediated Life Span Reduction

Andreas Schlotterer, G Kukudov, Farastuk Bozorgmehr et al. · Diabetes · 2009 · 296 citations · Full text

Life Sciences, Biochemistry, Physiology +17

Glyoxalase‐1 prevents mitochondrial protein modification and enhances lifespan in <i> Caenorhabditis elegans</i>

Michael Morcos, Xueliang Du, Friederike Pfisterer et al. · Aging Cell · 2008 · 273 citations

Life Sciences, Biochemistry, Biology +17

<i>EML4‐ALK</i> fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK⁺ non‐small cell lung cancer

Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr et al. · International Journal of Cancer · 2018 · 137 citations · Full text

Medicine, Oncology, Pathology +17

Identification of a highly lethal V3⁺TP53⁺ subset in ALK⁺ lung adenocarcinoma

Petros Christopoulos, Martina Kirchner, Farastuk Bozorgmehr et al. · International Journal of Cancer · 2018 · 106 citations · Full text

Medicine, Oncology, Pathology +17

Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer

Giannis Mountzios, Epaminontas Samantas, K. Senghas et al. · ESMO Open · 2021 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17